Heading into 2025, a handful of mega-cap tech companies had tilted the U.S. public equity markets meaningfully into growth ...
An analysis cited in HealthExec of the Walgreens buy from the SEC 8-K filing indicates that Sycamore Partners’ offer is a near-classic leveraged buyout, with Sycamore taking on much more debt than ...